Droxidopa
In Stock•Starting at $58 for 10 mg•Purity ≥ 98%
| CAS No. | 23651-95-8 |
|---|---|
| MDL No. | MFCD00799030 |
| MF | C9H11NO5 |
| MW | 213.19 |
| InChI Key | QXWYKJLNLSIPIN-JGVFFNPUSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 10 mg | 98% | $58 | In Stock | |
| 50 mg | 98.0% | $112 | In Stock | |
| 200 mg | 98.0% | $421 | In Stock | |
| 250 mg | >98.0% | $519 | In Stock | |
| 1 g | >98.0% | $1587 | In Stock |
Product Information
Droxidopa is an L-serine derivative with a 3,4-dihydroxyphenyl group at the beta-position. It serves as a prodrug for noradrenalone and is used to treat neurogenic orthostatic hypotension. It functions as a prodrug, vasoconstrictor, and antihypertensive agent. It is also an L-tyrosine derivative and a member of the catechol class.
| CAS No. | 23651-95-8 |
|---|---|
| Product Name | Droxidopa |
Biological Targets
ADRA1A·ADRA2A·ADRB1·ADRB2·ADRA2C·
Associated Conditions
fibromyalgia·Parkinson disease·orthostatic intolerance·multiple system atrophy·hypotension·
* The information provided here is compiled from public sources and is for reference only.
